NovaBay Pharmaceuticals Inc Financial Flexibility Index
NovaBay Pharmaceuticals Inc financial flexibility index. NovaBay Pharmaceuticals Inc (NBY) has a Financial Flexibility Index of -0.07x as of December 2025. Free cash flow of $-2.27 Million (operating CF $-2.27 Million minus capex $0.00) represents 0% of total liabilities ($31.86 Million). See NovaBay Pharmaceuticals Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of NovaBay Pharmaceuticals Inc (2005–2025)
Financial flexibility index of NovaBay Pharmaceuticals Inc from 2005 to 2025. Historical Financial Flexibility Index trend for NovaBay Pharmaceuticals Inc across 21 annual periods. Check NovaBay Pharmaceuticals Inc (NBY) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
NovaBay Pharmaceuticals Inc Financial Flexibility Index by Year (2005–2025)
NovaBay Pharmaceuticals Inc financial flexibility index by year from 2005 to 2025. Year-by-year free cash flow to debt coverage for NovaBay Pharmaceuticals Inc. For the full cash flow conversion analysis, see NBY operating cash flow.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.26x | $-8.43 Million | $-8.43 Million | $31.86 Million | ▲ +81.8% |
| 2024 | -1.46x | $-5.18 Million | $-5.18 Million | $3.55 Million | ▼ -96.5% |
| 2023 | -0.74x | $-4.24 Million | $-4.26 Million | $5.72 Million | ▲ +33.7% |
| 2022 | -1.12x | $-6.54 Million | $-6.65 Million | $5.84 Million | ▼ -69.1% |
| 2021 | -0.66x | $-9.14 Million | $-9.19 Million | $13.81 Million | ▲ +58.8% |
| 2020 | -1.61x | $-4.70 Million | $-4.72 Million | $2.92 Million | ▼ -108.3% |
| 2019 | -0.77x | $-7.91 Million | $-7.93 Million | $10.25 Million | ▲ +38.4% |
| 2018 | -1.25x | $-5.52 Million | $-5.57 Million | $4.41 Million | ▼ -55.7% |
| 2017 | -0.81x | $-6.03 Million | $-6.27 Million | $7.49 Million | ▲ +44.3% |
| 2016 | -1.45x | $-11.97 Million | $-12.13 Million | $8.28 Million | ▲ +20.2% |
| 2015 | -1.81x | $-18.44 Million | $-18.56 Million | $10.18 Million | ▲ +31.2% |
| 2014 | -2.63x | $-14.99 Million | $-15.05 Million | $5.69 Million | ▼ -46.5% |
| 2013 | -1.80x | $-12.83 Million | $-12.97 Million | $7.13 Million | ▼ -46.2% |
| 2012 | -1.23x | $-6.38 Million | $-6.53 Million | $5.19 Million | ▼ -169.4% |
| 2011 | -0.46x | $-3.02 Million | $-3.14 Million | $6.62 Million | ▼ -202.9% |
| 2010 | 0.44x | $2.23 Million | $2.03 Million | $5.03 Million | ▲ +302.2% |
| 2009 | -0.22x | $-917.00K | $-1.65 Million | $4.18 Million | ▲ +84.4% |
| 2008 | -1.41x | $-9.33 Million | $-9.94 Million | $6.62 Million | ▼ -141.2% |
| 2007 | -0.58x | $-5.61 Million | $-6.27 Million | $9.60 Million | ▼ -215.0% |
| 2006 | 0.51x | $5.11 Million | $4.74 Million | $10.05 Million | ▲ +105.1% |
| 2005 | -10.02x | $-3.11 Million | $-3.23 Million | $310.00K | — |